OrbiMed’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-465,000
| Closed | -$81.8M | – | 125 |
|
|
2025
Q2 | $81.8M | Hold |
465,000
| – | – | 2.06% | 15 |
|
|
2025
Q1 | $62.5M | Sell |
465,000
-327,000
| -41% | -$43.1M | 1.5% | 21 |
|
|
2024
Q4 | $100M | Buy |
792,000
+10,000
| +1% | +$1.49M | 2.08% | 12 |
|
|
2024
Q3 | $130M | Sell |
782,000
-391,300
| -33% | -$59.2M | 2.38% | 9 |
|
|
2024
Q2 | $156M | Hold |
1,173,300
| – | – | 3.1% | 9 |
|
|
2024
Q1 | $123M | Sell |
1,173,300
-51,100
| -4% | -$4.59M | 2.26% | 10 |
|
|
2023
Q4 | $92.5M | Hold |
1,224,400
| – | – | 1.85% | 15 |
|
|
2023
Q3 | $80.7M | Buy |
1,224,400
+263,900
| +27% | +$19.7M | 1.73% | 18 |
|
|
2023
Q2 | $78.2M | Sell |
960,500
-259,800
| -21% | -$18.5M | 1.43% | 25 |
|
|
2023
Q1 | $72.5M | Hold |
1,220,300
| – | – | 1.44% | 21 |
|
|
2022
Q4 | $59.5M | Buy |
1,220,300
+577,000
| +90% | +$26.7M | 1.14% | 32 |
|
|
2022
Q3 | $33.2K | Sell |
643,300
-13,000
| -2% | -$772K | 0.62% | 55 |
|
|
2022
Q2 | $34.5K | Buy |
656,300
+28,000
| +4% | +$1.95M | 0.63% | 51 |
|
|
2022
Q1 | $54M | Buy |
628,300
+329,300
| +110% | +$27.1M | 0.88% | 37 |
|
|
2021
Q4 | $24.4M | Sell |
299,000
-12,700
| -4% | -$928K | 0.31% | 76 |
|
|
2021
Q3 | $20.7M | Buy |
+311,700
| New | +$22.1M | 0.23% | 94 |
|
|
2019
Q1 | – | Sell |
-562,785
| Closed | -$9.65M | – | 141 |
|
|
2018
Q4 | $9.65M | Buy |
+562,785
| New | +$13.6M | 0.18% | 85 |
|
|
2018
Q3 | – | Sell |
-372,900
| Closed | -$12.5M | – | 160 |
|
|
2018
Q2 | $12.5M | Sell |
372,900
-3,816,400
| -91% | -$119M | 0.15% | 106 |
|
|
2018
Q1 | $102M | Buy |
+4,189,300
| New | +$83.4M | 1.27% | 27 |
|
|
2017
Q2 | – | Sell |
-5,352,000
| Closed | -$94.8M | – | 148 |
|
|
2017
Q1 | $94.8M | Buy |
5,352,000
+1,635,300
| +44% | +$30.3M | 1.08% | 31 |
|
|
2016
Q4 | $55.2M | Buy |
3,716,700
+1,723,700
| +86% | +$30.9M | 0.71% | 44 |
|
|
2016
Q3 | $45.2M | Buy |
1,993,000
+1,077,700
| +118% | +$28.1M | 0.52% | 54 |
|
|
2016
Q2 | $25.3M | Buy |
+915,300
| New | +$27M | 0.27% | 70 |
|
Other funds holding THC
GCM
